Amanote Research
Register
Sign In
Pcp44 - Implications of Genome-Driven Oncology on Evidence Requirements for Health Technology Assessment
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.519
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
I. Leslie
Publisher
Elsevier BV
Related search
A Comparison of Health Technology Assessment (HTA) Requirements for Systematic Literature Reviews (SLRS)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn280 - Impact of Suboptimal Clinical Evidence on Health Technology Assessment Recommendations
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Technology Assessment in Radiation Oncology: Time for Reassessment?
Nature Clinical Practice Oncology
Health Technology Performance Assessment: Real-World Evidence for Public Healthcare Sustainability
International Journal of Technology Assessment in Health Care
Health Policy
Prm148 - Health Technology Assessment Agency Appraisal of Immuno-Oncology Cure Fraction Survival Modelling
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn382 - Quality of Life in Long-Term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
BMA Calls for Evidence on Ethical Implications of New Genetic Technology
BMJ
Unintended Consequences of Health Information Technology: Evidence From Veterans Affairs Colorectal Cancer Oncology Watch Intervention
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Pmd171 - Health Technology Assessment of Companion Diagnostics Alongside Therapeutc Agents in Oncology: Experience of the Nice Technology Appraisal Programme
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
